Search

everythinglearnresearchcommunity

for

Search:↓

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Finasteride may lower cholesterol and slow heart disease progression.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Hair loss may increase heart disease risk.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Higher levels of small, dense LDL cholesterol are linked to a greater risk of heart attack in young adults.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Lower LDL-c levels predict higher COVID-19 mortality.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Vegetable protein lowers cholesterol and protein deficiency can cause health issues.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

People with male pattern baldness are more likely to have metabolic syndrome.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.